|
|
| SC6A7_HUMAN |
SLC6A7 |
Sodium-dependent proline transporter |
4.369e-107 |
0.41
|
| FGFR2_HUMAN |
FGFR2 |
Fibroblast growth factor receptor 2 |
4.239e-52 |
0.50
|
| CHK2_HUMAN |
CHEK2 |
Serine/threonine-protein kinase Chk2 |
9.999e-52 |
0.42
|
| Q4DCQ3_TRYCC |
|
Superoxide dismutase |
9.946e-48 |
0.31
|
| LMBL4_HUMAN |
L3MBTL4 |
Lethal(3)malignant brain tumor-like protein 4 |
3.537e-44 |
0.35
|
| ACACA_RAT |
Acaca |
Acetyl-CoA carboxylase 1 |
3.896e-43 |
0.47
|
| FAS_HUMAN |
FASN |
Fatty acid synthase |
2.634e-42 |
0.36
|
| CD209_HUMAN |
CD209 |
CD209 antigen |
5.166e-42 |
0.33
|
| FGFR3_HUMAN |
FGFR3 |
Fibroblast growth factor receptor 3 |
5.443e-37 |
0.50
|
| CCKAR_HUMAN |
CCKAR |
Cholecystokinin receptor type A |
1.186e-36 |
0.33
|
| FGFR1_HUMAN |
FGFR1 |
Fibroblast growth factor receptor 1 |
5.789e-35 |
0.50
|
| HRH4_HUMAN |
HRH4 |
Histamine H4 receptor |
1.981e-29 |
0.44
|
| B9W6M3_CANDC |
CNA1 |
Serine/threonine-protein phosphatase |
2.79e-28 |
0.44
|
| PGDH_HUMAN |
HPGD |
15-hydroxyprostaglandin dehydrogenase [NAD(+)] |
8.55e-28 |
0.39
|
| NCAP_I33A0 |
NP |
Nucleoprotein |
1.196e-26 |
0.33
|
| ACACA_HUMAN |
ACACA |
Acetyl-CoA carboxylase 1 |
2.746e-26 |
0.46
|
| GP183_MOUSE |
Gpr183 |
G-protein coupled receptor 183 |
2.556e-25 |
0.32
|
| PRKDC_MOUSE |
Prkdc |
DNA-dependent protein kinase catalytic subunit |
3.332e-25 |
0.31
|
| INHA_MYCTU |
inhA |
Enoyl-[acyl-carrier-protein] reductase [NADH] |
2.444e-24 |
0.41
|
| SC6A5_HUMAN |
SLC6A5 |
Sodium- and chloride-dependent glycine transporter 2 |
4.515e-23 |
0.34
|
| FAS_RAT |
Fasn |
Fatty acid synthase |
1.807e-22 |
0.33
|
| 5HT3A_CAVPO |
HTR3A |
5-hydroxytryptamine receptor 3A |
2.892e-22 |
0.35
|
| Q91ZY3_CAVPO |
HRH4 |
Histamine H4 receptor |
1.419e-20 |
0.33
|
| AK1C3_HUMAN |
AKR1C3 |
Aldo-keto reductase family 1 member C3 |
3.297e-19 |
0.35
|
| PDE3B_HUMAN |
PDE3B |
cGMP-inhibited 3',5'-cyclic phosphodiesterase B |
1.495e-18 |
0.32
|
| BCL9_HUMAN |
BCL9 |
B-cell CLL/lymphoma 9 protein |
6.229e-18 |
0.28
|
| LIPL_BOVIN |
LPL |
Lipoprotein lipase |
8.104e-18 |
0.28
|
| PA2GA_HUMAN |
PLA2G2A |
Phospholipase A2, membrane associated |
1.274e-17 |
0.38
|
| Q1L4E8_MACMU |
|
Mas-related G protein-coupled receptor X1 |
1.882e-17 |
0.33
|
| PRIO_SHEEP |
PRNP |
Major prion protein |
3.249e-17 |
0.29
|
| VGFR2_MOUSE |
Kdr |
Vascular endothelial growth factor receptor 2 |
4.95e-17 |
0.33
|
| REV1_HUMAN |
REV1 |
DNA repair protein REV1 |
1.11e-16 |
0.38
|
| TP53B_HUMAN |
TP53BP1 |
TP53-binding protein 1 |
5.551e-16 |
0.35
|
| PAR12_HUMAN |
PARP12 |
Protein mono-ADP-ribosyltransferase PARP12 |
7.105e-15 |
0.28
|
| PAR16_HUMAN |
PARP16 |
Protein mono-ADP-ribosyltransferase PARP16 |
7.105e-15 |
0.28
|
| GP183_HUMAN |
GPR183 |
G-protein coupled receptor 183 |
3.231e-14 |
0.32
|
| GYRB_MYCS2 |
gyrB |
DNA gyrase subunit B |
8.349e-14 |
0.32
|
| Q0GMK6_RABIT |
CDK4 |
Cyclin-dependent kinase 4 |
3.891e-13 |
0.40
|
| AGP1_YEAST |
AGP1 |
General amino acid permease AGP1 |
4.11e-13 |
0.38
|
| HPGDS_HUMAN |
HPGDS |
Hematopoietic prostaglandin D synthase |
9.258e-13 |
0.31
|
| ALR_HUMAN |
GFER |
FAD-linked sulfhydryl oxidase ALR |
1.849e-12 |
0.40
|
| PDE3A_HUMAN |
PDE3A |
cGMP-inhibited 3',5'-cyclic phosphodiesterase A |
2.473e-12 |
0.32
|
| GYRB_MYCSM |
gyrB |
DNA gyrase subunit B |
2.531e-12 |
0.36
|
| LRRK2_HUMAN |
LRRK2 |
Leucine-rich repeat serine/threonine-protein kinase 2 |
2.704e-12 |
0.33
|
| MRGX2_HUMAN |
MRGPRX2 |
Mas-related G-protein coupled receptor member X2 |
3.05e-12 |
0.30
|
| LYPA2_HUMAN |
LYPLA2 |
Acyl-protein thioesterase 2 |
3.497e-12 |
0.30
|
| SC6A9_HUMAN |
SLC6A9 |
Sodium- and chloride-dependent glycine transporter 1 |
1.266e-11 |
0.40
|
| AL1A1_HUMAN |
ALDH1A1 |
Retinal dehydrogenase 1 |
1.34e-11 |
0.37
|
| KCNA5_HUMAN |
KCNA5 |
Potassium voltage-gated channel subfamily A member 5 |
1.345e-11 |
0.34
|
| NMDE2_RAT |
Grin2b |
Glutamate receptor ionotropic, NMDA 2B |
1.436e-11 |
0.37
|
| DCTP1_HUMAN |
DCTPP1 |
dCTP pyrophosphatase 1 |
1.534e-11 |
0.36
|
| LYAG_HUMAN |
GAA |
Lysosomal alpha-glucosidase |
2.083e-11 |
0.36
|
| PA21B_PIG |
PLA2G1B |
Phospholipase A2, major isoenzyme |
2.86e-11 |
0.38
|
| MRGX1_HUMAN |
MRGPRX1 |
Mas-related G-protein coupled receptor member X1 |
3.209e-11 |
0.37
|
| Q3Y5H1_9GAMC |
|
3C-like protease |
1.099e-10 |
0.36
|
| S27A1_HUMAN |
SLC27A1 |
Long-chain fatty acid transport protein 1 |
1.202e-10 |
0.31
|
| ENPP3_HUMAN |
ENPP3 |
Ectonucleotide pyrophosphatase/phosphodiesterase family member 3 |
9.719e-10 |
0.31
|
| PAR15_HUMAN |
PARP15 |
Protein mono-ADP-ribosyltransferase PARP15 |
1.012e-09 |
0.28
|
| NOD1_HUMAN |
NOD1 |
Nucleotide-binding oligomerization domain-containing protein 1 |
1.32e-09 |
0.42
|
| MP2K4_HUMAN |
MAP2K4 |
Dual specificity mitogen-activated protein kinase kinase 4 |
2.964e-09 |
0.32
|
| ACACB_HUMAN |
ACACB |
Acetyl-CoA carboxylase 2 |
3.86e-09 |
0.46
|
| NAMPT_HUMAN |
NAMPT |
Nicotinamide phosphoribosyltransferase |
4.416e-09 |
0.44
|
| PARP1_HUMAN |
PARP1 |
Poly [ADP-ribose] polymerase 1 |
4.906e-09 |
0.47
|
| BTK_HUMAN |
BTK |
Tyrosine-protein kinase BTK |
5.243e-09 |
0.32
|
| MGLL_HUMAN |
MGLL |
Monoglyceride lipase |
5.81e-09 |
0.32
|
| LMBL3_HUMAN |
L3MBTL3 |
Lethal(3)malignant brain tumor-like protein 3 |
6.928e-09 |
0.35
|
| NOD2_HUMAN |
NOD2 |
Nucleotide-binding oligomerization domain-containing protein 2 |
1.267e-08 |
0.35
|
| PAR14_HUMAN |
PARP14 |
Protein mono-ADP-ribosyltransferase PARP14 |
1.816e-08 |
0.29
|
| HRH4_MOUSE |
Hrh4 |
Histamine H4 receptor |
1.946e-08 |
0.33
|
| NR0B1_HUMAN |
NR0B1 |
Nuclear receptor subfamily 0 group B member 1 |
3.985e-08 |
0.29
|
| PGFRB_MOUSE |
Pdgfrb |
Platelet-derived growth factor receptor beta |
4.043e-08 |
0.33
|
| HRH3_HUMAN |
HRH3 |
Histamine H3 receptor |
7.393e-08 |
0.34
|
| GPR6_HUMAN |
GPR6 |
G-protein coupled receptor 6 |
1.14e-07 |
0.38
|
| TEC_HUMAN |
TEC |
Tyrosine-protein kinase Tec |
1.169e-07 |
0.30
|
| CXCR3_HUMAN |
CXCR3 |
C-X-C chemokine receptor type 3 |
1.199e-07 |
0.32
|
| MBTD1_HUMAN |
MBTD1 |
MBT domain-containing protein 1 |
2.798e-07 |
0.35
|
| GRM5_RAT |
Grm5 |
Metabotropic glutamate receptor 5 |
6.067e-07 |
0.36
|
| PADI4_HUMAN |
PADI4 |
Protein-arginine deiminase type-4 |
1.023e-06 |
0.28
|
| IDE_HUMAN |
IDE |
Insulin-degrading enzyme |
1.057e-06 |
0.32
|
| LMBL1_HUMAN |
L3MBTL1 |
Lethal(3)malignant brain tumor-like protein 1 |
1.095e-06 |
0.35
|
| ALK_HUMAN |
ALK |
ALK tyrosine kinase receptor |
1.264e-06 |
0.34
|
| PGFRB_HUMAN |
PDGFRB |
Platelet-derived growth factor receptor beta |
1.466e-06 |
0.43
|
| PK3CD_MOUSE |
Pik3cd |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform |
1.841e-06 |
0.28
|
| DHI1_HUMAN |
HSD11B1 |
Corticosteroid 11-beta-dehydrogenase isozyme 1 |
2.273e-06 |
0.45
|
| MP2K7_HUMAN |
MAP2K7 |
Dual specificity mitogen-activated protein kinase kinase 7 |
4.182e-06 |
0.32
|
| CP2C9_HUMAN |
CYP2C9 |
Cytochrome P450 2C9 |
4.684e-06 |
0.39
|
| JAK2_HUMAN |
JAK2 |
Tyrosine-protein kinase JAK2 |
5.452e-06 |
0.38
|
| CCNC_HUMAN |
CCNC |
Cyclin-C |
5.507e-06 |
0.30
|
| M9TGV3_MYCTX |
inhA |
Enoyl-[acyl-carrier-protein] reductase [NADH] |
5.669e-06 |
0.36
|
| PE2R2_HUMAN |
PTGER2 |
Prostaglandin E2 receptor EP2 subtype |
6.478e-06 |
0.35
|
| HRH4_RAT |
Hrh4 |
Histamine H4 receptor |
7.303e-06 |
0.33
|
| NCEH1_HUMAN |
NCEH1 |
Neutral cholesterol ester hydrolase 1 |
9.307e-06 |
0.36
|